Trimedyne, Inc. announced earnings results for the fiscal year ended September 30, 2018. For the fiscal year ended September 30, 2018, the company had revenues of $5,567,000, an increase of 18.6% from revenues of $4,695,000 for the prior year. The company had net income for the current year of $234,000 or $1.91 per share, as compared to a net loss of $44,000 or $0.36 per share for the prior year, adjusted for a 150 to one reverse stock split in November, 2016. This $278,000 increase compared to the prior fiscal year is a considerable improvement, which was primarily the result of the increase in sales stated above.